Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of detaching cells – digesting tissue or establishing...
Reexamination Certificate
2007-02-15
2011-12-06
Chen, Shin-Lin (Department: 1632)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of detaching cells, digesting tissue or establishing...
C435S325000, C435S384000
Reexamination Certificate
active
08071380
ABSTRACT:
The present invention discloses the isolation and characterization of cells isolated either from adult skeletal muscle or from adult cardiac muscle. These cells are used for the treatment of muscular disorders including muscular dystrophy and cardiopathics, respectively.
REFERENCES:
patent: 6387369 (2002-05-01), Pittenger et al.
patent: 2003/0216332 (2003-11-01), Chamberlain et al.
patent: 2005/0181502 (2005-08-01), Furcht et al.
patent: 2006/0111290 (2006-05-01), Itescu
patent: 2006/0239983 (2006-10-01), Anversa
patent: 2006/0286544 (2006-12-01), Mandal et al.
patent: 1999/003973 (1999-01-01), None
patent: 1999049015 (1999-09-01), None
patent: 2001/094420 (2001-12-01), None
patent: 2002097066 (2002-12-01), None
patent: 2003006950 (2003-01-01), None
patent: 2003/024462 (2003-03-01), None
patent: 2003095631 (2003-11-01), None
patent: 2004019767 (2004-03-01), None
patent: 2005/012510 (2005-02-01), None
patent: 2006/011061 (2006-02-01), None
Allegrucci et al., 2006, Human Reproduction Update, Vol. Advance Access published on Aug. 26, 2006, p. 1-18.
Sato et al., 2003, Developmental Biology, vol. 260, p. 404-413.
Rao, M., 2004, Developmental Biology, vol. 275, p. 269-286.
Abeyta et al., 2004, Human Molecular Genetics, vol. 13, No. 6, p. 601-608.
Yu et al., 2006, American Journal of Pathology, vol. 168, No. 6, p. 1-6.
Cotsarelis, G., 2006, The Journal of Clinical Investigation, vol. 116, No. 1, p. 19-22.
International Search Report; PCT/EP2007/001309; published Nov. 22, 2007.
Bergers, et al, “The role of pericytes in blood-vessel formation and maintenance,” Neuro-Oncology, Jul. 2005, pp. 452-464, Society for Neuro-Oncology, San Francisco, CA.
Dellavalle, et al., “Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells,” Nature Cell Biology, Mar. 2007, pp. 255-267, vol. 9, No. 3.
Guttinger, et al., “Allogeneic mesoangioblasts give rise to alpha-sarcoglycan expressing fibers when transplanted into dystrophic mice, ” Science Direct, Aug. 2006, pp. 3872-3879, Experimental Cell Research 312, Elsevier, Inc.
Morosetti, et al., “MyoD expression restores defective myogenic differentiation of human mesoangioblasts from inclusion-body myositis, ” PNAS, Nov. 7, 2006, pp. 16995-17000, vol. 103, No. 45, The National Academy of Sciences of the USA.
Sampaolesi, et al., “Cell Therapy of Alpha-Sarcoglycan Null Dystrophic Mice Through Intra-Arterial Delivery of Mesoangioblasts,” Science, Jul. 25, 2003, pp. 487-492, vol. 301, www.sciencemag.org.
Sampaolesi, et al., “Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs,” Nature, Nov. 15, 2006, pp. 1-6, www.nature.com, Nature Publishing Group.
Reyes, et al., “Purification and ex vivo expansion of postnatal human marrow mesodermal progenitor cells,” Blood, Nov. 1, 2001, pp. 2615-2625, vol. 98, No. 9, W.B. Saunders Company, Orlando, FL, US.
Minasi, et al., “The meso-angioblast: a multipotent, self-renewing cell that originates from the dorsal aorta and differentiates into most mesodermal tissues, ” Development 129, Jun. 2002, pp. 2772-2783, The Company of Biologists Limited 2002, Cambridge, GB.
Yin, et al., “AC133, a Novel Marker for Human Hematopoietic Stem and Progenitor Cells,” Blood, Dec. 15, 1997, pp. 5002-5012, vol. 90, No. 12, W.B. Saunders Company, Orlando, FL, US.
Cossu, et al. “Mesoangioblasts, vessel associated stem cells, repair skeletal muscle in animal models of muscular dystrophies,” Experimental Hematology, Jul. 2005, pp. 39-72, New York, NY, US, and ABSTRACTS of Oral Presentations, 34th Annual Meeting, International-Society-for-Experimental Hematology, Abstract No. 8, Jul. 30-Aug. 2, 2005, Glasgow, Scotland.
Messina, et al., “Isolation and Expansion of Adult Cardiac Stem Cells From Human and Murine Heart,” Research, Journal of the American Heart Association, Oct. 29, 2004, pp. 911-921, The American Heart Associate, Dallas, Texas and Supplemental Material, 22 pages downloaded from circres.ahajounals.org at Fondazione Centro San Raffaele on Dec. 20, 2010.
Condorelli, et al., “Cardiomyocytes induce endothelial cells to trans-differentiate into cardiac muscle: Implications for myocardium regeneration,” PNAS, Sep. 11, 2001, pp. 10733-10738, vol. 98, No. 19.
Dezawa, et al., “Bone Marrow Stromal Cells Generate Muscle Cells and Repair Muscle Degeneration,” Science, Jul. 8, 2005, pp. 314-317, vol. 309, American Association for the Advancement of Science (AAAS), Washington, D.C.
Orlic, et al., “Bone Marrow Cells Regenerate Infarcted Myocardium,” Nature, Apr. 5, 2001, pp. 701-705, vol. 410, Macmillan Magazine Ltd.
Kocher, et al., “Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function,” Nature Medicine, Apr. 2001, pp. 430-436, vol. 7, No. 4, Nature Publishing Group.
Sciorati, et al, “Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy,” Journal of Cell Science, Oct. 12, 2006, pp. 5114-5123, vol. 119, The Company of Biologists.
Galvez, et al., “Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability,” The Journal of Cell Biology, Jul. 17, 2006, pp. 231-243, vol. 174, No. 2, The Rockefeller University Press.
Brachvogel, et al., “Perivascular cells expressing annexin A5 define a novel mesenchymal stem cell-like population with the capacity to differentiate into multiple mesenchymal lineages,” Development and disease, Mar. 22, 2005, pp. 2657-2668, vol. 132, The Company of Biologists.
Galli, et al., “Mesoangioblasts, Vessel-Associated Multipotent Stem Cells, Repair the Infarcted Heart by Multiple Cellular Mechanisms,” Arterioscler Thromb Vasc Biol., Apr. 2005, pp. 1-6, The American Heart Association, Dallas, Texas.
Cossu, et al., “New Therapies for muscular dystrophy: cautious optimism,” Trends in Molecular Medicine, Oct. 2004, pp. 516-520, vol. 10, No. 10.
Cossu Giulio
Galvez Gonzales Beatriz
Tonlorenzi Rossana
Chen Shin-Lin
Fondazione Centro San Raffaele Del Monte Tabor
Lucas & Mercanti LLP
LandOfFree
Skeletal muscle periangioblasts and cardiac mesangioblasts,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Skeletal muscle periangioblasts and cardiac mesangioblasts,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Skeletal muscle periangioblasts and cardiac mesangioblasts,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4303931